Jacobs Levy Equity Management, Inc Xencor Inc Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Xencor Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 207,622 shares of XNCR stock, worth $4.88 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
207,622
Previous 305,673
32.08%
Holding current value
$4.88 Million
Previous $5.79 Million
27.84%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding XNCR
# of Institutions
216Shares Held
71.7MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$261 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$215 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$179 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$125 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$92.3 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.4B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...